IL6 and systemic sclerosis: Noteworthy, when fibroblasts from patients with dcSSc were used as an in-vitro model, we observed a significant difference in the modulation of IL-6 and IL-8 secretion levels in response to stimulation with all SSc-ICs as well as NHS-ICs.